Gabelli Funds’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-432,378
| Closed | -$29.4M | – | 1395 |
|
|
2022
Q3 | $29.4M | Buy |
432,378
+413,178
| +2,152% | +$28.1M | 0.24% | 114 |
|
|
2022
Q2 | $613K | Buy |
19,200
+200
| +1% | +$6.39K | ﹤0.01% | 966 |
|
|
2022
Q1 | $658K | Hold |
19,000
| – | – | ﹤0.01% | 991 |
|
|
2021
Q4 | $556K | Sell |
19,000
-8,824
| -32% | -$258K | ﹤0.01% | 1041 |
|
|
2021
Q3 | $709K | Sell |
27,824
-19,000
| -41% | -$484K | ﹤0.01% | 984 |
|
|
2021
Q2 | $1.64M | Buy |
46,824
+20,500
| +78% | +$718K | 0.01% | 799 |
|
|
2021
Q1 | $1.07M | Buy |
+26,324
| New | +$1.07M | 0.01% | 878 |
|
|
2019
Q4 | – | Sell |
-12,000
| Closed | -$582K | – | 1145 |
|
|
2019
Q3 | $582K | Hold |
12,000
| – | – | ﹤0.01% | 937 |
|
|
2019
Q2 | $631K | Hold |
12,000
| – | – | ﹤0.01% | 958 |
|
|
2019
Q1 | $635K | Hold |
12,000
| – | – | ﹤0.01% | 941 |
|
|
2018
Q4 | $493K | Sell |
12,000
-2,000
| -14% | -$82.2K | ﹤0.01% | 969 |
|
|
2018
Q3 | $532K | Buy |
14,000
+2,500
| +22% | +$95K | ﹤0.01% | 1000 |
|
|
2018
Q2 | $520K | Buy |
11,500
+4,500
| +64% | +$203K | ﹤0.01% | 996 |
|
|
2018
Q1 | $338K | Buy |
+7,000
| New | +$338K | ﹤0.01% | 1040 |
|